Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02733250 |
| Title | Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer (URCOH-PMS-001) |
| Acronym | URCOH-PMS-001 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Centre hospitalier de l'Université de Montréal (CHUM) |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | CAN |
CKB BOOST